CFA
APGN

Carroll Financial Associates’s Apexigen, Inc. Common Stock APGN Stock Holding History

Carroll Financial Associates’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$2K Hold
290
– – ﹤0.01% 1513
2021
Q3 		$2K Hold
290
– – ﹤0.01% 1590
2021
Q2 		$2K Buy
+290
New +$2.87K ﹤0.01% 1599

Other funds holding APGN

PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Carroll Financial Associates's APGN Position: Q4 2021 in Review

Carroll Financial Associates held its Apexigen, Inc. Common Stock (APGN) position steady in Q4 2021 at 290 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1513.

Carroll Financial Associates first reported a position in APGN in Q2 2021 and has held it in 3 quarters since. 38 funds tracked by Wall St. Rank hold APGN as of Q4 2021.

  • Carroll Financial Associates held 290 shares of Apexigen, Inc. Common Stock worth $2K as of Q4 2021.
  • Carroll Financial Associates left its Apexigen, Inc. Common Stock share count unchanged in Q4 2021.
  • Apexigen, Inc. Common Stock made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1513 holding.
  • Carroll Financial Associates first reported a position in Apexigen, Inc. Common Stock in Q2 2021 and has held it in 3 quarters since.
  • 38 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.